145 related articles for article (PubMed ID: 2449758)
1. Spontaneous circadian fluctuations of prostate specific antigen and prostatic acid phosphatase serum activities in patients with prostatic cancer.
Mannini D; Maver P; Aiello E; Corrado G; Vecchi F; Bellanova B; Marengo M
Urol Res; 1988; 16(1):9-12. PubMed ID: 2449758
[TBL] [Abstract][Full Text] [Related]
2. [Prostate-specific antigen. A new biological serum marker for prostatic adenocarcinoma].
Haukaas S; Skaarland E; Halvorsen OJ; Stensland E; Farstad M
Tidsskr Nor Laegeforen; 1990 Sep; 110(23):2990-3. PubMed ID: 1700496
[TBL] [Abstract][Full Text] [Related]
3. Serum prostate-specific antigen: hourly change/24 hours compared with prostatic acid phosphatase.
el-Shirbiny AM; Nilson T; Pawar HN
Urology; 1990 Jan; 35(1):88-92. PubMed ID: 1688677
[TBL] [Abstract][Full Text] [Related]
4. Relative value of prostate-specific antigen and prostatic acid phosphatase in diagnosis and management of adenocarcinoma of prostate. Ohio State University experience.
Drago JR; Badalament RA; Wientjes MG; Smith JJ; Nesbitt JA; York JP; Ashton JJ; Neff JC
Urology; 1989 Oct; 34(4):187-92. PubMed ID: 2477931
[TBL] [Abstract][Full Text] [Related]
5. Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate.
Stamey TA; Yang N; Hay AR; McNeal JE; Freiha FS; Redwine E
N Engl J Med; 1987 Oct; 317(15):909-16. PubMed ID: 2442609
[TBL] [Abstract][Full Text] [Related]
6. Daily variability in human serum prostate-specific antigen and prostatic acid phosphatase: a comparative evaluation.
Dejter SW; Martin JS; McPherson RA; Lynch JH
Urology; 1988 Oct; 32(4):288-92. PubMed ID: 2459831
[TBL] [Abstract][Full Text] [Related]
7. Clinical utility of prostatic specific antigen and prostatic acid phosphatase serum levels in monitoring prostate cancer.
Morote J; Ruibal A; Palou J; de Torres JA; Soler-Roselló A
Int J Biol Markers; 1988; 3(1):23-8. PubMed ID: 2470838
[TBL] [Abstract][Full Text] [Related]
8. Comparative experimental study of the serum prostate specific antigen and prostatic acid phosphatase in serially transplantable human prostatic carcinoma lines in nude mice.
Csapo Z; Brand K; Walther R; Fokas K
J Urol; 1988 Nov; 140(5):1032-8. PubMed ID: 2459419
[TBL] [Abstract][Full Text] [Related]
9. The role of prostate specific antigen as a tumor marker in men with advanced adenocarcinoma of the prostate.
Maatman TJ
J Urol; 1989 Jun; 141(6):1378-80. PubMed ID: 2470927
[TBL] [Abstract][Full Text] [Related]
10. Comparative study of the clinical usefulness of prostate specific antigen and prostatic acid phosphatase in prostatic disease.
Buamah PK; Johnson P; Skillen AW
Br J Urol; 1988 Dec; 62(6):581-3. PubMed ID: 2464396
[TBL] [Abstract][Full Text] [Related]
11. Clinical usefulness of prostate-specific antigen and prostatic acid phosphatase in patients with prostatic cancer.
Filella X; Molina R; Jo J; Umbert B; Bedini JL; Ballesta AM
Tumour Biol; 1990; 11(6):289-94. PubMed ID: 1700860
[TBL] [Abstract][Full Text] [Related]
12. The contribution of prostatic acid phosphatase and prostatic specific antigen in the diagnosis of prostatic cancer.
van Dalen A; Helmhout DH; van Caubergh RD
Int J Biol Markers; 1988; 3(2):123-6. PubMed ID: 2468722
[TBL] [Abstract][Full Text] [Related]
13. Prostate specific antigen in the diagnosis and treatment of adenocarcinoma of the prostate. II. Radical prostatectomy treated patients.
Stamey TA; Kabalin JN; McNeal JE; Johnstone IM; Freiha F; Redwine EA; Yang N
J Urol; 1989 May; 141(5):1076-83. PubMed ID: 2468795
[TBL] [Abstract][Full Text] [Related]
14. Prostate-specific antigen as a marker of adenocarcinoma of prostate.
Kellokumpu-Lehtinen P; Nurmi M; Koskinen P; Irjala K
Urol Res; 1989; 17(4):245-9. PubMed ID: 2475959
[TBL] [Abstract][Full Text] [Related]
15. Serum prostatic acid phosphatase, gamma-seminoprotein and prostatic specific antigen in hemodialysis patients.
Sasagawa I; Nakada T; Hashimoto T; Ishigooka M; Kubota Y; Hirano K; Hirano J; Suzuki Y
Urol Int; 1992; 48(2):181-3. PubMed ID: 1374977
[TBL] [Abstract][Full Text] [Related]
16. Relationship between diurnal rhythm of serum testosterone and two prostatic markers (PSA and PAP) in untreated prostate cancer.
Akimoto S; Masai M; Shimazaki J
Urology; 1994 Mar; 43(3):337-41. PubMed ID: 7510912
[TBL] [Abstract][Full Text] [Related]
17. The role of serum prostatic acid phosphatase as a tumor marker in men with advanced adenocarcinoma of the prostate.
Maatman TJ; Gupta MK; Montie JE
J Urol; 1984 Jul; 132(1):58-60. PubMed ID: 6726962
[TBL] [Abstract][Full Text] [Related]
18. An evaluation of the immunochemical measurement of prostatic acid phosphatase and prostatic specific antigen in carcinoma of the prostate.
Siddall JK; Cooper EH; Newling DW; Robinson MR; Whelan P
Eur Urol; 1986; 12(2):123-30. PubMed ID: 2420600
[TBL] [Abstract][Full Text] [Related]
19. Comparison of prostate-specific antigen and prostatic acid phosphatase in the management of prostatic cancer.
Turkes A; Nott J; Turkes AO; Griffiths K
Am J Clin Oncol; 1988; 11 Suppl 2():S77-9. PubMed ID: 2468280
[TBL] [Abstract][Full Text] [Related]
20. Clinical behavior of prostatic specific antigen and prostatic acid phosphatase: a comparative study.
Morote Robles J; Ruibal Morell A; Palou Redorta J; de Torres Mateos JA; Soler Roselló A
Eur Urol; 1988; 14(5):360-6. PubMed ID: 2458936
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
